FIELD: pharmacology.
SUBSTANCE: invention relates to a pharmaceutical composition for sleep initiating and maintaining and prophylaxis of animal and human states that are accompanied by sleep disorders of a different nature, including a combination of active agents consisting of 0.5-45 mg of doxylamine succinate and long-acting melatonin in amount of 0.1-20 mg.
EFFECT: synergistic therapeutic effect and reduced side effects.
2 cl, 1 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING MENTAL, BEHAVIOUR AND COGNITIVE DISORDERS | 2012 |
|
RU2488388C1 |
| PHARMACEUTICAL COMPOSITIONS BASED ON N-CARBAMOYL-METHYL-4-PHENYL-2-PYRROLIDONE | 2012 |
|
RU2560691C2 |
| PHARMACEUTICAL COMPOSITION COMPRISING MELATONIN AND DIPHENHYDRAMINE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, DOSAGE FORM BASED ON PHARMACEUTICAL COMPOSITION COMPRISING MELATONIN AND DIPHENHYDRAMINE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, METHOD FOR PREPARING AND USING DOSAGE FORM BASED ON PHARMACEUTICAL COMPOSITION CONTAINING MELATONIN AND DIPHENHYDRAMINE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | 2021 |
|
RU2818092C1 |
| PHARMACEUTICAL COMPOSITION IN FORM OF TABLET AND METHOD OF OBTAINING THEREOF | 2014 |
|
RU2546002C1 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF DEPRESSIONS | 2011 |
|
RU2475235C2 |
| COMBINED HYPNOTIC AGENT IN THE FORM OF TABLETS | 2021 |
|
RU2769988C1 |
| COMPOSITION WITH RAPID ONSET EFFECT | 2001 |
|
RU2266744C2 |
| PHARMACEUTICAL COMPOSITION OF FABOMOTIZOLE DIHYDROCHLORIDE | 2022 |
|
RU2828872C2 |
| PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF VIRAL DISEASES | 2021 |
|
RU2780252C1 |
| PHARMACEUTICAL PREPARATION FOR ORAL USE BASED ON RALOXYPHENE OR ITS DERIVATIVES | 1995 |
|
RU2118540C1 |
